1. Home
  2. MRVI vs ANNA Comparison

MRVI vs ANNA Comparison

Compare MRVI & ANNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • ANNA
  • Stock Information
  • Founded
  • MRVI 2014
  • ANNA 2007
  • Country
  • MRVI United States
  • ANNA United States
  • Employees
  • MRVI N/A
  • ANNA N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • ANNA
  • Sector
  • MRVI Health Care
  • ANNA
  • Exchange
  • MRVI Nasdaq
  • ANNA NYSE
  • Market Cap
  • MRVI 312.4M
  • ANNA 366.3M
  • IPO Year
  • MRVI 2020
  • ANNA N/A
  • Fundamental
  • Price
  • MRVI $2.67
  • ANNA $4.66
  • Analyst Decision
  • MRVI Hold
  • ANNA
  • Analyst Count
  • MRVI 10
  • ANNA 0
  • Target Price
  • MRVI $6.84
  • ANNA N/A
  • AVG Volume (30 Days)
  • MRVI 1.9M
  • ANNA 32.4K
  • Earning Date
  • MRVI 08-06-2025
  • ANNA 08-15-2025
  • Dividend Yield
  • MRVI N/A
  • ANNA N/A
  • EPS Growth
  • MRVI N/A
  • ANNA N/A
  • EPS
  • MRVI N/A
  • ANNA N/A
  • Revenue
  • MRVI $241,856,000.00
  • ANNA $2,064,630.00
  • Revenue This Year
  • MRVI N/A
  • ANNA N/A
  • Revenue Next Year
  • MRVI $10.62
  • ANNA N/A
  • P/E Ratio
  • MRVI N/A
  • ANNA N/A
  • Revenue Growth
  • MRVI N/A
  • ANNA N/A
  • 52 Week Low
  • MRVI $1.67
  • ANNA $4.40
  • 52 Week High
  • MRVI $10.03
  • ANNA $18.70
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 59.30
  • ANNA N/A
  • Support Level
  • MRVI $2.52
  • ANNA N/A
  • Resistance Level
  • MRVI $2.93
  • ANNA N/A
  • Average True Range (ATR)
  • MRVI 0.18
  • ANNA 0.00
  • MACD
  • MRVI 0.03
  • ANNA 0.00
  • Stochastic Oscillator
  • MRVI 69.41
  • ANNA 0.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About ANNA ALEANNA INC

AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy. It is also involved in drilling, testing, and tie-in-related activities associated with three incremental Longanesi development wells.

Share on Social Networks: